endothelin-1 and Prostatitis

endothelin-1 has been researched along with Prostatitis* in 2 studies

Other Studies

2 other study(ies) available for endothelin-1 and Prostatitis

ArticleYear
[Expressions of differential proteins in the expressed prostatic secretion of patients with III A chronic prostatitis].
    Zhonghua nan ke xue = National journal of andrology, 2013, Volume: 19, Issue:9

    To study the expressions of differential proteins in the expressed prostatic secretion (EPS) of patients with III A chronic prostatitis and healthy men.. We collected EPS samples from 35 patients with III A chronic prostatitis and 18 age-matched healthy men, and detected the differentially expressed proteins in EPS by MALDI-TOF/MS. Based on the data obtained, we conducted a statistical analysis on the mass-to-charge (m/z) ratios of different proteins and a retrieval analysis on the relevant proteins using the protein database.. In the comparative studies of the III A chronic prostatitis patients and healthy men, 5 proteins were detected as at least 2-fold differentially expressed, which were probably brevinin-2Eg, big endothelin-1, alpha-defensin 15, beta-defensin 134 and prostatic steroid-binding protein C2. The m/z ratios were significantly up-regulated in 3 372, 3 487, 425 and 5 325 Da proteins (P < 0.01) and down-regulated in 10631Da (P < 0.01).. Proteins are differentially expressed in the EPS of III A chronic prostatitis patients and healthy men, and these proteins may be significantly correlated with the development and progression of III A chronic prostatitis.

    Topics: Adult; Body Fluids; Case-Control Studies; Chronic Disease; Defensins; Endothelin-1; Humans; Male; Prostate; Prostatitis; Young Adult

2013
[Clinical and experimental study of treatment of nanmiqing capsule for chronic prostatitis].
    Zhonghua nan ke xue = National journal of andrology, 2002, Volume: 8, Issue:5

    To investigate the clinical effect and therapeutic mechanism of Nanmiqing capsule made of rheum palmatum, leech, astragalus memberanaceus on patients with chronic prostatitis(CP).. Seventy-six CP cases were treated with Nanmiqing, while 32 CP cases were treated with Qianliekang as a control. The changes of EPS were observed pre- and post-treatment. The rat model of CP got by Xiaozhiling inducing were treated with Nanmiqing and Qianliekang respectively. The concentration of endothelin, TXB2, 6-keto-PGF1 alpha and SOD, IgG, IgA in plasma were measured pre- and post-treatment, meanwhile, pathological changes of prostate tissues were observed.. The total effective rate was 89.47% in treatment group, which was significantly higher than 71.88% in the control group (P < 0.01). Experimental study for CP rats showed that the Nanmiqing was more effective medicine than Qianliekang (P < 0.01).. Nanmiqing was an effective medicine for CP. The mechanism of clearing heat and resolving toxin, activating blood and removing stasis and reinforcing Qi in chinese medicine could be the explanation of the useful treatment including three therapentic ways.

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Capsules; Chronic Disease; Drugs, Chinese Herbal; Endothelin-1; Humans; Immunoglobulin A; Immunoglobulin G; Male; Middle Aged; Prostatitis; Superoxide Dismutase; Thromboxane B2; Treatment Outcome

2002